Navigation Links
Children's Hospital Boston, CompuCyte Corporation Establish International Quantitative Imaging Cytometry Center
Date:6/18/2009

BOSTON, June 18 /PRNewswire/ -- Children's Hospital Boston and CompuCyte Corporation today announced the establishment of an International Quantitative Imaging Cytometry Center of Excellence in Boston, to be jointly run by the two organizations. Under their agreement, Children's Hospital Boston and CompuCyte will create an educational resource focusing on training programs and symposia for scientists using laser scanning cytometry in cell- and tissue-based research. The Center represents an expansion of the existing Centers of Excellence programs currently operating at Cold Spring Harbor Laboratory in New York and the National University of Singapore.

Under the agreement, the Center will hold an annual symposium devoted to advances in Quantitative Imaging Cytometry. The first symposium is planned for August 2010 at Children's Hospital Boston.

"The establishment of the QIC Center at Children's Hospital Boston is the outgrowth of productive collaborations between research teams in the Longwood Medical Area and CompuCyte Corporation," said Dr. Leslie Silberstein, Director of the Joint Program in Transfusion Medicine and Center for Human Cell Therapy at Children's Hospital Boston. "We anticipate that the QIC Center, and the annual symposium in particular, will foster cross-disciplinary collaborations employing quantitative image cytometry in a multiplicity of cancer and stem cell research programs."

"The creation of a worldwide network of QIC Centers has been prompted by the rapidly expanding quantitative imaging cytometry network based on CompuCyte's laser scanning cytometry technology, and the growing number of applications to which it is being applied, especially in the areas of cancer and stem cell research," said Dr. Elena Holden, CompuCyte's President and CEO. "The Boston area's international reputation as an important hub of life science research and education makes it a natural site for the Center's operation, and we are pleased to partner with Children's Hospital Boston in this endeavor."

An advisory committee consisting of recognized experts in the field of cellular research will guide the Center:

  • Leslie Silberstein, M.D., Director of the Joint Program in Transfusion Medicine, Children's Hospital Boston and Professor of Pathology, Harvard Medical School

  • Robert Hongbo Luo, Ph.D., Assistant Professor of Pathology, Joint Program in Transfusion Medicine, Children's Hospital Boston, Harvard Medical School

  • Jerome Ritz, M.D., Medical Director, Connell and O'Reilly Cell Manipulation Core Facility, Dana-Farber Cancer Institute, Professor of Medicine, Harvard Medical School

  • Lynda Chin, M.D., Dana Farber Cancer Institute, Associate Professor of Medicine, Harvard Medical School

  • James Jacobberger, Ph.D., Professor of Oncology, Case Western Reserve University and Director, Cell Analysis Core, Case Comprehensive Cancer Center, Cleveland OH

  • Elena Holden, M.D., President and CEO, CompuCyte Corporation

Children's Hospital Boston is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 500 scientists, including eight members of the National Academy of Sciences, 11 members of the Institute of Medicine and 12 members of the Howard Hughes Medical Institute comprise Children's research community. Founded as a 20-bed hospital for children, Children's Hospital Boston today is a 397-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Children's also is the primary pediatric teaching affiliate of Harvard Medical School. The hospital has a long and collaborative history with most of the local academic and health care institutions and private industry partners in promoting basic and translational research. Its partnerships reach beyond Boston, throughout New England to many other U.S. academic and health care institutions and pharmaceutical companies. It currently has research agreements with more than 235 industry partners. For more information about the hospital and its research, visit www.childrenshospital.org.

CompuCyte Corporation, a private company headquartered in Westwood, Massachusetts, is a leader in the development of cellular analysis instrumentation for life science research, drug safety, toxicology studies and clinical trials. The company's iCyte(R), iCys(R), and iColor(R) cytometers enable quantitative cytometric image analysis of cellular and tissue specimens. More information about the technology may be found at www.compucyte.com.


'/>"/>
SOURCE CompuCyte Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. 200 Families of Children With Serious Eye Problems Benefit From Unique Gift Card Program at The Vision Center at Childrens Hospital Los Angeles
2. Childrens Bedding Naturally Enhances Emotional Well-being
3. Cydcor Builds Bears and Bonds in Special Charity Event Benefitting Childrens Hospital Los Angeles
4. National Childrens Study Begins Recruiting
5. Jessica Biel and Make The Difference Network Bring Holiday Cheer to Childrens Hospital Los Angeles
6. Siegel+Gale Designs New HOPE Portal for Childrens Hospital Los Angeles
7. Childrens Hospital Los Angeles Turns Off the Tap With Green Earth Waterless Carwash
8. Nautica Malibu Triathlon Presented by Toyota Raises $718,000 for Childrens Hospital Los Angeles Pediatric Cancer Research
9. St. Charles Surgical Hospital Announces Dedicated Lymphedema Treatment Program
10. U.S. News & World Report Ranks Children's National Medical Center among Best Children's Hospitals
11. Childrens Hospital of Philadelphia Earns Highest Combined US News Score in 10 Specialties Ranked by U.S. News & World Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... Phytomer USA ... As a Phytomer Account Manager, Smith’s role is to provide excellent customer ... that make up The Phytomer Group. Smith comes to Phytomer with a wealth of ...
(Date:4/28/2017)... ... April 28, 2017 , ... The National Campaign to ... the Access to Contraception for Women Servicemembers and Dependents Act of 2017. The ... will help to ensure that all members of the Armed Forces receive high ...
(Date:4/28/2017)... ... April 28, 2017 , ... Horizon Blue Cross Blue Shield of New Jersey ... “A” and its outlook as “stable.” At the same time, the ratings agency cautioned ... recent years, dip below “capital adequacy” thresholds required for its strong rating. , “Horizon ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Radiology Business Management ... officers for 2017-2018. The annual board election process has been in place since the ... , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, FRBMA, as president. ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... liability could substantially improve drug safety and minimize the cost of development. In ... ion channel inhibition using cell lines and for cardiac toxicity using induced pluripotent ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017  Novartis today announced the publication ... Lung, and Blood Institute (NHLBI) of the National ... patients with treatment-naïve severe aplastic anemia (SAA) achieved ... eltrombopag at the initiation of and concurrently with ... three sequential treatment groups, or cohorts. Cohort 3 ...
(Date:4/18/2017)... MINNEAPOLIS , April 18, 2017 Cogentix ... focused on providing the Urology, Uro/Gyn and Gynecology markets ... for the first quarter ended March 31, 2017 after ... The Company will host a conference call ... day on Tuesday, May 2, 2017 at 4:30 p.m. ...
(Date:4/18/2017)... , April 18, 2017  Astute Medical, Inc., developer ... series to be presented at the 2017 National Kidney ... today and continues through April 22. Physicians will present ... used to assess risk for acute kidney injury (AKI) ... failure (ADHF). Elevated levels of TIMP-2 ...
Breaking Medicine Technology: